Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Association between diffuse panbronchiolitis and HTLV-I infection]

H Mukae1, Y Higashiyama, T Morikawa

  • 1Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|January 1, 1994
PubMed
Summary

Human T-lymphotropic virus type I (HTLV-I) infection may be linked to distinct lung conditions resembling diffuse panbronchiolitis (DPB). Further research is needed to understand these HTLV-I-associated pulmonary lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024
Same author

Evaluation of QFT-Plus performance using blood samples stored at room temperature.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

First clinical evaluation of the QIAreach<sup>TM</sup> QuantiFERON-TB for tuberculosis infection and active pulmonary disease.

Pulmonology·2021
Same author

IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis.

Journal of internal medicine·2020
Same author

Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.

Alimentary pharmacology & therapeutics·2015
Same author

Thin-section CT findings in Pseudomonas aeruginosa pulmonary infection.

The British journal of radiology·2012

Area of Science:

  • Immunology
  • Pulmonology
  • Virology

Background:

  • Diffuse panbronchiolitis (DPB) is a chronic airway disease.
  • The association between HTLV-I infection and DPB requires further investigation.
  • T-cell surface markers are crucial for understanding immune responses in lung diseases.

Observation:

  • Peripheral blood T-cell profiles did not significantly differ between healthy volunteers and HTLV-I-negative DPB patients.
  • Bronchoalveolar lavage fluid (BALF) in HTLV-I-negative DPB patients showed a decreased CD4/CD8 ratio and increased CD8+HLA-DR+ cells compared to healthy volunteers.
  • HTLV-I-positive DPB patients exhibited elevated CD3+CD25+ and CD4+HLA-DR+ cells in peripheral blood compared to HTLV-I-negative DPB patients.

Findings:

  • A marked elevation of CD3+CD25+ cells was observed in a subset of HTLV-I-positive patients.

Related Experiment Videos

  • Lung biopsy findings in these HTLV-I-positive patients differed from typical DPB.
  • These results suggest HTLV-I infection might be associated with a distinct type of pulmonary lesion.

    • Implications:

    • HTLV-I infection may play a role in specific pulmonary pathologies.
    • Understanding the distinct immunological profiles associated with HTLV-I is crucial for diagnosis and treatment.
    • Further research into HTLV-I-associated lung diseases could reveal new therapeutic targets.